Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proteomic Signature Associated With Clinical Response to Cytarabine Based Induction Therapy in Patients With AML 56 Years and Older

NCT01338974 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT01338974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01338974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proteomic Signature Associated With Clinical Response to Cytarabine Based Induction Therapy in Patients With AML 56 Years and Older
Lead sponsor
SWOG Cancer Research Network
Phase
Observational
Overall status
Completed
Start date
March 31, 2011
Completion date
August 31, 2012
Enrollment
290 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia